BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23317651)

  • 1. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
    Khuthaila MK; Hsu J; Chiang A; DeCroos FC; Milder EA; Setlur V; Garg SJ; Spirn MJ
    Am J Ophthalmol; 2013 Apr; 155(4):757-63, 763.e1-2. PubMed ID: 23317651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary repair of retinal detachment with 25-gauge pars plana vitrectomy.
    Miller DM; Riemann CD; Foster RE; Petersen MR
    Retina; 2008; 28(7):931-6. PubMed ID: 18698293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
    Nadal J; Carreras E; Canut MI
    Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
    Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
    Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-three-gauge pars plana vitrectomy, Densiron-68, and 360° endolaser versus combined 20-gauge pars plana vitrectomy, scleral buckle, and SF6 for pseudophakic retinal detachment with inferior retinal breaks.
    Romano MR; Angi M; Valldeperas X; Costagliola C; Vinciguerra P
    Retina; 2011 Apr; 31(4):686-91. PubMed ID: 21386767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcomes of 23-gauge pars plana vitrectomy.
    Gupta OP; Ho AC; Kaiser PK; Regillo CD; Chen S; Dyer DS; Dugel PU; Gupta S; Pollack JS
    Am J Ophthalmol; 2008 Aug; 146(2):193-197. PubMed ID: 18547538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
    Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
    Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
    Yeh PT; Yang CH; Yang CM
    Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
    Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
    Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of 25-gauge pars plana vitrectomy in the surgical management of proliferative diabetic retinopathy.
    Schoenberger SD; Miller DM; Riemann CD; Foster RE; Sisk RA; Hutchins RK; Petersen MR
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):474-80. PubMed ID: 21902167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
    Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
    Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of vitreous hemorrhage secondary to exudative age-related macular degeneration.
    Hasegawa T; Otani A; Sasahara M; Gotoh N; Ooto S; Tamura H; Yamashiro K; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2010 Feb; 149(2):322-329.e1. PubMed ID: 20103057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
    Lee DY; Jeong HS; Sohn HJ; Nam DH
    Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
    Ahn J; Woo SJ; Chung H; Park KH
    Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment.
    Weichel ED; Martidis A; Fineman MS; McNamara JA; Park CH; Vander JF; Ho AC; Brown GC
    Ophthalmology; 2006 Nov; 113(11):2033-40. PubMed ID: 17074564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
    Hartley KL; Smiddy WE; Flynn HW; Murray TG
    Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes.
    Schiff WM; Barile GR; Hwang JC; Tseng JJ; Cekiç O; Del Priore LV; Chang S
    Ophthalmology; 2007 Mar; 114(3):544-50. PubMed ID: 17169431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.
    Jahn CE; Töpfner von Schutz K; Richter J; Boller J; Kron M
    Ophthalmologica; 2004; 218(6):378-84. PubMed ID: 15564755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.